Donor Telomeres and Their Magnitude of Shortening Post-Allogeneic Hematopoietic Cell Transplant Impact Survival for Patients with Early-Stage Leukemia or Myelodysplastic Syndrome

Researchers evaluated the potential impact of donor leukocyte telomere length (LTL) and LTL shortening in recipients at three-month post-hematopoetic cell transplant (HCT) on the two-year HCT outcomes.